Member Info for JimiHendrix

Russ is the finance man and he’s putting in the most, that tells you something.

Not sure it will, the new shares won't be admitted to trading until June and then I'd expect a build up to the NICE news. I can't imagine many will sell before that.

Just go to the corporate action menu item and then you’ll see the open offer and simply follow the instructions.

It briefly dropped to 1.5p last week, I can't see it dropping there again as it would probably lead to the company not being able to raise the minimum amount required (as the open offer would no longer look like good value), which would be a disaster, probably resulting in no investment case so I can't see any logic in hoping for that scenario.

Personally I think it'll move up simply because there are not currently many shares in issue and there's positive appetite for the open offer shares, which to qualify for of course requires buying/holding shares over the coming weeks. Usually I'd expect the shareprice to stay around the placing price but not in these circumstances, the only reason for it to drop to there again imo would be if the fundraise was unsuccessful and that is very unlikely because it will result in the company being forced into desperate measures (delisting or huge dilution) which won't be good for anyone. So imo anybody wanting to have shares at 1.5p is going to have to take part in the fundraise in order to make any money, which should push the shareprice up and I can't imagine anybody selling in June with the NICE news a few weeks away.

Hopefully we'll have a really good run. News on new go live sites for AIHL can't be far away either, rollout to NICU sites in Kent, Surrey and Sussex is coming.

The NHS could face legal action if they don't follow the guidance.

Implications of avoiding the guidance...

Whilst the word ‘guidelines’ may conjure the impression of discretionary and optional advice, this is far from the case. Following the landmark case of Montgomery -v- Lanarkshire (2015) the way that practitioners dealt with consenting patients for operations significantly altered. Legal principles established through case law are binding and they cannot be ignored. The case law on NICE guidelines is likely to have the same effect. When making a decision about how to treat a patient, ignoring and failing to adhere to the NICE guidelines is likely to lead to legal consequences.

There’s no minimum period for holding the open offer shares once received. I’m not sure about the ISA question, I am still waiting to receive the offer from my broker. I think most will receive it after the circular has been sent out, this week I believe.

NICE full recommendation in July, UKCA marking and the devote study all coinciding around the same time should result in sales beginning straight away. The NHS will clearly need to follow NICE’s recommendation and order the test.

The open offer will increase demand imo as people will need to hold shares in order to take part. Then once the shares have been issued in June it will be a matter of weeks until the July NICE news and not many will be selling in the lead up to that, quite the opposite.

Muminr, the REX shares will be needed if they are to reach the £3.9m worth that they need for the fundraise to go ahead, I'm not buying the REX shares but will vote in favor of them. The open offer shares are not enough by themselves, they amount to about £2m.

Nissan, the shares being issued on Wednesday are negligible, only £170k worth.

9p will equate to £50m mcap with the new shares, providing they raise the £6m required.

Also the REX offer is open to new and existing shareholders. Maybe they've got a large buyer lined up to take part in the REX offer.

Muminr, JC didn't say another hospital was going live actually, what he said was a couple more sites are coming on-board. I believe there are 10 or so sites that are trying to get the test, they're going through the process of obtaining funding.

Initially I misunderstood too, but realised after rewatching.

Guy, no not at all! The times I have been talking positively about the company and sharing my thoughts on potential upside were the times I was buying.

Muminr, I think some of what the company says is controlled by the Nomad / Broker and not necessarily what management wants to say. I'm always questioning their conduct and my main gripe is transparency, I wish they would explain their reasoning behind everything they do or don't do as that would build trust and help to quash conspiracy theories. They have done this quite well in the presentations but twice a year is not enough, it should be regular.

What I found odd was how often JC mentioned how much he wanted to find long term funding, his manner just made me think they had already arranged funding and were told not to disclose. Russ's body language made me question that too. However nothing was announced for weeks which made me think they may take up the £1.5m from RF with minimal dilution and wait until after NICE before doing a fundraise. I expect this funding has been in the works for many months.

I've decided to buy more in the open offer, as I see considerable upside next month leading to July, providing they receive the amount they need. If they don't receive it and the funding doesn't go ahead, then the money is returned.

Guy, I trade it. I hold for as long as I feel comfortable (usually months) and then sell some if I think there is no longer a high chance of further near term upside.

I believe we'll have revenue from several new AIHL sites in H2 plus revenue from the stroke marker test after NICE and UKCA marking. Potentially revenue from selling the stroke marker test for research purposes into Europe during this time too, before CE-IVD marking which is expected early next year.

Plus specialist commissioning for AIHL expected in 9 months time (April 2025), and if that comes through then revenue should really start rolling in.

When the shares are admitted to trading it will only be a few weeks before July NICE news - doubt it’ll drop at that point, there will likely be huge demand.

As the CEO I'm surprised he's not at least matching Ross's £25k.